Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy
- Rodger David MacArthur(corresponding author),
- George Perez,
- Sharon Walmsley,
- John D. Baxter,
- Christopher M. Mullin,
- James D. Neaton
- Wayne State University,
- North Jersey Comm. Res. Initiative,
- University of Toronto,
- Rowan University,
- University of Minnesota Twin Cities
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
<p>The comparative prognostic importance of latest plasma HIV RNA levels (viral loads) and CD4+ cell counts among patients prescribed highly active antiretroviral therapy (HAART) has not been well characterized. Method: We assessed the prognostic value of latest CD4+ cell counts and latest viral loads for progression to AIDS or death and explored their interaction among 432 HIV-infected persons with advanced HIV who were prescribed a protease inhibitor (PI) as their first HAART regimen. Results: Pre-HAART median CD4+ cell count and viral load were 41 cells/mm<sup>3</sup> and 126,331 copies/mL, respectively. After 12 months of HAART, the median CD4+ cell count was 154 cells/mm<sup>3</sup>; 39% of patients had a viral load of 400 copies/ mL or lower. Over a median follow-up of 33 months, 109 (25%) of the 432 patients experienced an AIDS event or died. The hazard ratio for AIDS or death for those with latest CD4+ cell count <50 cells/mm<sup>3</sup> versus ≥200 cells/mm<sup>3</sup> was 13.9 (95% CI 6.5 to 29.7) without adjustment for latest viral load measurements and 9.5 (95% CI 4.0 to 22.5) after adjustment for latest viral load. In contrast, the hazard ratio for AIDS or death for those with viral load ≥100,000 versus <400 copies/mL was 4.2 (95% CI 2.3 to 7.7) without adjustment for latest CD4+ level and 1.2 (95% CI 0.6 to 2.4) with adjustment for latest CD4+ cell count. Conclusion: We conclude that when latest CD4+ cell count and viral load are considered separately, both are significantly related to AIDS or death; when these markers are jointly considered, the association of viral load with AIDS or death is substantially diminished. Latest CD4+ levels are more strongly related to AIDS or death than latest viral load levels in patients on HAART.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 127-135 (9 pages)Journal (Volume, Issue Number)
HIV Clinical Trials (Volume 6, Issue 3)Publication milestones
- Published - 05/2005
Publication status
Published - 05/2005
ISSN
1528-4336Publication IDs
- Scopus: 25144446840
- PubMed: 16192247
Publication metrics
Metrics
SciVal
FWCI
0.61
SciVal
Author count
6
SciVal
citations
17
SciVal
Paper percentile
70
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
18
Captures
21
Funding Details
FunderFunding number
NIAID
U01AI042170
